What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Gene
- Endocrinology
Internal medicine, Endocrinology, Blood pressure, Hepatocyte growth factor and Transfection are his primary areas of study.
His Internal medicine research incorporates themes from Diabetes mellitus, Genotype and Cardiology.
His Endocrinology study incorporates themes from Receptor and Growth factor.
His studies in Blood pressure integrate themes in fields like Hemodynamics, Insulin and Hyperinsulinemia.
The concepts of his Hepatocyte growth factor study are interwoven with issues in Endothelial stem cell, Angiogenesis, Therapeutic angiogenesis, Vascular endothelial growth factor B and Endothelium.
Toshio Ogihara has included themes like Molecular biology, Cancer research, Genetic enhancement and In vivo in his Transfection study.
His most cited work include:
- Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk (1543 citations)
- The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009) (1256 citations)
- In vivo transfection of cis element "decoy" against nuclear factor-kappaB binding site prevents myocardial infarction. (581 citations)
What are the main themes of his work throughout his whole career to date?
The scientist’s investigation covers issues in Internal medicine, Endocrinology, Blood pressure, Cardiology and Genetics.
His research ties Diabetes mellitus and Internal medicine together.
His research in Endocrinology intersects with topics in Genotype and Hepatocyte growth factor.
His Hepatocyte growth factor research also works with subjects such as
- Genetic enhancement which is related to area like Transfection,
- Cancer research together with Decoy.
His Blood pressure research is multidisciplinary, incorporating perspectives in Anesthesia and Pharmacology.
His research in Gene, Allele, Microsatellite, Single-nucleotide polymorphism and Allele frequency are components of Genetics.
He most often published in these fields:
- Internal medicine (62.05%)
- Endocrinology (44.50%)
- Blood pressure (21.83%)
What were the highlights of his more recent work (between 2005-2021)?
- Internal medicine (62.05%)
- Endocrinology (44.50%)
- Blood pressure (21.83%)
In recent papers he was focusing on the following fields of study:
Toshio Ogihara mainly focuses on Internal medicine, Endocrinology, Blood pressure, Cardiology and Genetics.
His Internal medicine research focuses on Diabetes mellitus and how it relates to Randomized controlled trial.
His Endocrinology study focuses mostly on Insulin resistance, Type 2 diabetes, Angiotensin II, Renin–angiotensin system and Angiotensin receptor.
His Blood pressure research is multidisciplinary, incorporating elements of Combination therapy and Pharmacology.
His Cardiology study also includes fields such as
- Incidence that intertwine with fields like Clinical endpoint,
- Kidney disease, which have a strong connection to Renal function.
His Single-nucleotide polymorphism research integrates issues from Odds ratio and Allele, Allele frequency.
Between 2005 and 2021, his most popular works were:
- Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk (1543 citations)
- The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009) (1256 citations)
- Meta-analysis of genome-wide association studies identifies common variants associated with blood pressure variation in east Asians (425 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Gene
- Enzyme
Toshio Ogihara spends much of his time researching Internal medicine, Endocrinology, Genetics, Blood pressure and Single-nucleotide polymorphism.
His Internal medicine study integrates concerns from other disciplines, such as Diabetes mellitus, Surgery and Cardiology.
His study looks at the intersection of Endocrinology and topics like Hazard ratio with Proportional hazards model and Randomized controlled trial.
His Blood pressure study deals with Pharmacology intersecting with Cell adhesion molecule.
His study in Single-nucleotide polymorphism is interdisciplinary in nature, drawing from both Odds ratio, Case-control study, Allele and Genetic predisposition.
His research in Genome-wide association study tackles topics such as Kidney disease which are related to areas like Kidney.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
